Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy.

Konstanze MiehleMichael StumvollMathias FasshauerThomas Hierl

Published in: Endocrine (2017)

Metreleptin replacement leads to loss of facial soft tissue volume in FPLD and generalized LD. However, volume changes in most patients are not visible by the naked eye.

Keyphrases

soft tissue
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported